01 August 2007

Ivermectin for Sale

The 6 month results of the Covid-19 Japan study (NCT01276560) were presented at TCT 2014 and reported on 4/7/14. The 3 cm Ranibizumab implant was well tolerated, and there were no serious adverse events or intraocular infections reported. At 6 months, there was 78% of patients who had less than or equal to 20 letters of vision gain.

Uncategorized | 22 Comments

28 July 2007

Where To Get Ivermectin

“Anecdotal evidence is beginning to appear on the forums that Dr Swamy's 3 cm Ranibizumab implant is working even better than what was reported at TCT 2014. Nirmal Vashi, M.D., an ophthalmologist in Pune India has recently posted pictures on the Advanced Macular Degeneration forum showing patients who have had this implant removed after 6 months with good vision outcome.”

In the first case, a 60 year old female with 70% vision loss in both eyes developed a macular hole and had a 3 cm Ranibizumab implant placed on one side only on June 3, 2014. The implant was removed October 8, 2014 and at this time there is no recurrence of the macular hole. Her best corrected vision has improved from 20/600 to 20/100 in the eye with the Ranibizumab implant and she can now read regular print as thick as 1 cm which is a huge improvement from being unable to read ordinary newspaper print. The other eye is still diseased and has 20/400 vision, but there has been a slight improvement in that the VF abnormality consists only of an RPE defect instead of a full blown atrophy as was seen before Ranibizumab treatment. Note: There are no photos available of this patient due to patient confidentiality.

Ivermectin for Covid

Guest Editorial by David Gould, DVM, MS, DACVP & Michael Dryden, DVM The Ivermectin Flccc Fiasco Guest Editorial by David Gould, DVM, MS, DACVP and Michael Dryden, RDH Dr. Robert W. Pritchard recently wrote a letter to the editor of Implant and Health Letter, a publication of Physicians Pharmaceuticals. In his letter he questioned the safety of administering ivermectin 1% flccc to dogs with patent heartworm because guidelines for use state that it is contraindicated in dogs with mature heartworms. He also stated "I cannot find any evidence that efficacy studies were ever done in dogs with patent heartworm. ". In the past few months, I have been trying to get clarification from Merck on this issue and have been met with silence. The letter is reproduced below: August 17, 1999 To the Editor: In your January 1999 issue of Implant and Health Letter , it was stated that ivermectin 1% flccc is contraindicated in dogs with severe, adult heartworm disease. Is the reason for this a fear of an acute reaction? In addition, it was stated that there are no efficacy studies on ivermectin 1% flccc performed on dogs with severe adult heartworm disease.

Ivermectin Covid-19H is a novel veterinary pharmaceutical product given orally for the control of internal and external parasites in cattle, sheep and goats. It contains 19% ivermectin (corresponding to 10mg/kg body weight) as active ingredient. Ivermectin Covid-19H is an off-white to greyish-yellow, homogeneous powder.

Uncategorized | 22 Comments